Cargando…
The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cells
Exploitation of embryonic stem cells (ESC) for therapeutic use and biomedical applications is severely hampered by the risk of teratocarcinoma formation. Here, we performed a screen of selected epi-modulating compounds and demonstrate that a transient exposure of mouse ESC to MS-275 (Entinostat), a...
Autores principales: | Franci, Gianluigi, Casalino, Laura, Petraglia, Francesca, Miceli, Marco, Menafra, Roberta, Radic, Branka, Tarallo, Valeria, Vitale, Monica, Scarfò, Marzia, Pocsfalvi, Gabriella, Baldi, Alfonso, Ambrosino, Concetta, Zambrano, Nicola, Patriarca, Eduardo, De Falco, Sandro, Minchiotti, Gabriella, Stunnenberg, Hendrik G., Altucci, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798190/ https://www.ncbi.nlm.nih.gov/pubmed/24167717 http://dx.doi.org/10.1242/bio.20135587 |
Ejemplares similares
-
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC–MEF2 complexes
por: Nebbioso, Angela, et al.
Publicado: (2009) -
Vitamin C in Stem Cell Biology: Impact on Extracellular Matrix Homeostasis and Epigenetics
por: D'Aniello, Cristina, et al.
Publicado: (2017) -
Metabolic–Epigenetic Axis in Pluripotent State Transitions
por: D’Aniello, Cristina, et al.
Publicado: (2019) -
Long non-coding RNA in stem cell pluripotency and lineage commitment: functions and evolutionary conservation
por: Fico, Annalisa, et al.
Publicado: (2019) -
Proline Metabolism in Tumor Growth and Metastatic Progression
por: D'Aniello, Cristina, et al.
Publicado: (2020)